Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal secretion and severe comorbidities. Some patients are resistant to medical therapies; therefore, novel treatment options are needed. Antagonists of growth hormone-releasing hormone (GHRH) exert potent anticanc...
Main Authors: | Iacopo Gesmundo, Giuseppina Granato, Antonio C. Fuentes-Fayos, Clara V. Alvarez, Carlos Dieguez, Maria Chiara Zatelli, Noemi Congiusta, Dana Banfi, Nunzia Prencipe, Sheila Leone, Luigi Brunetti, Justo P. Castaño, Raúl M. Luque, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew V. Schally, Riccarda Granata |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3950 |
Similar Items
-
Assessment of anthropometric and physical health indicators before and after pituitary surgery in patients with nonfunctioning pituitary adenomas, acromegaly, and Cushing disease
by: Cyro G S. Leães, et al.
Published: (2019-01-01) -
Difficulties in diagnosis of adenomas with mixed prolactin and growth hormone secretion: case presentation
by: Larisa K. Dzeranova, et al.
Published: (2020-12-01) -
Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
by: Christine Mathai, MD, et al.
Published: (2021-03-01) -
Evaluation of Factors Affecting Outcome in Growth Hormone–Secreting Pituitary Adenomas
by: Amit Padwal, et al.
Published: (2017-09-01) -
Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease
by: Anna Stroud, et al.
Published: (2023-01-01)